Predilife Market Cap ($3.68 Million)
Market Cap & Net Worth: Predilife (ALPRE)
Predilife market cap. Predilife (PA:ALPRE) has a market capitalization of $3.68 Million (€3.14 Million) as of November 8, 2026. Listed on the PA stock exchange, this France-based company holds position #29091 globally and #525 in its home market, demonstrating a -5.65% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Predilife's stock price €0.80 by its total outstanding shares 3919498 (3.92 Million). Also see how efficiently does Predilife generate cash for how efficiently the company converts equity into cash flow.
Predilife Market Cap History (2018–2026)
Predilife market cap history from 2018 to 2026. Data shows change from $42.84 Million to $3.68 Million (-26.72% CAGR). Check Predilife (ALPRE) share price today for real-time trading data and today's change.
Predilife Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Predilife's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Predilife (ALPRE) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
26.69x
Predilife's market cap is 26.69 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.08x
Predilife's market cap is 0.08 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $42.84 Million | $72.26K | -$2.37 Million | 592.94x | N/A |
| 2019 | $36.43 Million | $22.87K | -$2.10 Million | 1592.75x | N/A |
| 2020 | $33.22 Million | $51.57K | -$2.25 Million | 644.19x | N/A |
| 2021 | $31.62 Million | $142.08K | -$3.41 Million | 222.53x | N/A |
| 2022 | $24.38 Million | $288.60K | -$3.65 Million | 84.47x | N/A |
| 2023 | $26.12 Million | $317.79K | -$4.22 Million | 82.19x | N/A |
| 2024 | $16.50 Million | $618.06K | $198.63 Million | 26.69x | 0.08x |
Competitor Companies of ALPRE by Market Capitalization
Companies near Predilife in the global market cap rankings as of November 8, 2026. Also see ALPRE total assets for a full breakdown of the balance sheet.
Key companies related to Predilife by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #86 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $162.64 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #505 globally with a market cap of $53.20 Billion USD ( CN¥363.57 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #596 globally with a market cap of $44.78 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #86 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $694.76 |
| #143 | Danaher Corporation | NYSE:DHR | $162.64 Billion | $230.25 |
| #505 | WuXi AppTec Co Ltd | SHG:603259 | $53.20 Billion | CN¥147.00 |
| #596 | Natera Inc | NASDAQ:NTRA | $44.78 Billion | $310.67 |
Market Capitalization of Predilife (2018–2026)
Market capitalization of Predilife from 2018 to today. Between 2018 and today, Predilife's market cap moved from $42.84 Million to $ 3.68 Million, with a yearly change of -26.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €3.68 Million | -73.36% |
| 2025 | €13.79 Million | -16.39% |
| 2024 | €16.50 Million | -36.84% |
| 2023 | €26.12 Million | +7.14% |
| 2022 | €24.38 Million | -22.90% |
| 2021 | €31.62 Million | -4.83% |
| 2020 | €33.22 Million | -8.81% |
| 2019 | €36.43 Million | -14.97% |
| 2018 | €42.84 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Predilife was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.68 Million USD |
| MoneyControl | $3.68 Million USD |
| MarketWatch | $3.68 Million USD |
| marketcap.company | $3.68 Million USD |
| Reuters | $3.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Predilife
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more